Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H16N2O3 |
Molecular Weight | 224.2563 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC\C=C(/C)C1(CC)C(=O)NC(=O)NC1=O
InChI
InChIKey=RAFOHKSPUDGZPR-VOTSOKGWSA-N
InChI=1S/C11H16N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h6H,4-5H2,1-3H3,(H2,12,13,14,15,16)/b7-6+
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | DELVINAL Approved UseThe best therapeutic results are obtained in patients with psychoneuroses, manic-depressive manic or mixed psychoses, toxic or infectious psychoses—and, to a lesser extent, in patients with involutional melancholia. |
Doses
Dose | Population | Adverse events |
---|---|---|
32 mg single, oral Recommended Dose: 32 mg Route: oral Route: single Dose: 32 mg Sources: |
healthy n = 10 Health Status: healthy Population Size: 10 Sources: |
Other AEs: Epigastric discomfort, Nausea... Other AEs: Epigastric discomfort (2 patients) Sources: Nausea (2 patients) Dizziness (1 patient) Sweating (3 patients) Apprehension (1 patient) Fatigue (3 patients) |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Apprehension | 1 patient | 32 mg single, oral Recommended Dose: 32 mg Route: oral Route: single Dose: 32 mg Sources: |
healthy n = 10 Health Status: healthy Population Size: 10 Sources: |
Dizziness | 1 patient | 32 mg single, oral Recommended Dose: 32 mg Route: oral Route: single Dose: 32 mg Sources: |
healthy n = 10 Health Status: healthy Population Size: 10 Sources: |
Epigastric discomfort | 2 patients | 32 mg single, oral Recommended Dose: 32 mg Route: oral Route: single Dose: 32 mg Sources: |
healthy n = 10 Health Status: healthy Population Size: 10 Sources: |
Nausea | 2 patients | 32 mg single, oral Recommended Dose: 32 mg Route: oral Route: single Dose: 32 mg Sources: |
healthy n = 10 Health Status: healthy Population Size: 10 Sources: |
Fatigue | 3 patients | 32 mg single, oral Recommended Dose: 32 mg Route: oral Route: single Dose: 32 mg Sources: |
healthy n = 10 Health Status: healthy Population Size: 10 Sources: |
Sweating | 3 patients | 32 mg single, oral Recommended Dose: 32 mg Route: oral Route: single Dose: 32 mg Sources: |
healthy n = 10 Health Status: healthy Population Size: 10 Sources: |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C67084
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
||
|
WHO-VATC |
QN05CA09
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
||
|
DEA NO. |
2100
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
||
|
WHO-ATC |
N05CA09
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
766
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
PRIMARY | |||
|
75016-38-5
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
ALTERNATIVE | |||
|
3849
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
PRIMARY | |||
|
5284636
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
PRIMARY | |||
|
204-739-1
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
PRIMARY | |||
|
89811
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
PRIMARY | RxNorm | ||
|
7NZH2C1T6O
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
PRIMARY | |||
|
m985
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
PRIMARY | |||
|
C76530
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
PRIMARY | |||
|
VINBARBITAL
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
PRIMARY | |||
|
SUB00051MIG
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
PRIMARY | |||
|
DTXSID1023738
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
PRIMARY | |||
|
DB13377
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
PRIMARY | |||
|
100000079105
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
PRIMARY | |||
|
CHEMBL503565
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
PRIMARY | |||
|
125-42-8
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
PRIMARY | |||
|
117442
Created by
admin on Sat Dec 16 17:42:42 GMT 2023 , Edited by admin on Sat Dec 16 17:42:42 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)